3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Primary Myelofibrosis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Flow Cytometry
7
Blood Specimen Collection
5
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Cytogenetic Analysis
4
Biopsy
4
In Situ Hybridization, Fluorescence
3
fludarabine
2
Microarray Analysis
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Gene Expression Profiling
2
Cyclophosphamide
2
Bone Marrow Transplantation
2
luspatercept
1
Watchful Waiting
1
Vision, Ocular
1
Therapeutics
1
Respiratory Physiological Phenomena
1
Radioimmunodetection
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Molecular Diagnostic Techniques
1
Mesna
1
Mental Status and Dementia Tests
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Myelodysplastic Syndromes
×
luspatercept
×
Clear all
NCT01688011
2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
2,013 enrolled